Single-cell Omics Market Growth Drivers and Challenges:
Growth Drivers
- Extending field of applications: Advancements and wide commercialization of sequencing is broadening the utilization territory of the single-cell omics market. As this technique provides a comprehensive snapshot of gene expression profiles in cells, researchers are increasingly investing in this sector to identify and characterize distinct cell populations and subtypes within a tissue or organism. This garnering higher avenues for development and opportunities of business from various medical disciplines beyond oncology for this sector. This new line of applications includes: optimization of cell lines for biologics production, neuroscience, infectious disease, stem cell research, and clinical diagnostics.
- Tech-based integration in analysis: The single-cell omics market is rapidly evolving, driven by continuous advancements in technologies and methodologies. The enhanced workflow and seamless operation attract giant research institutions and fuel the demand for these innovative products. For instance, in June 2024, Mission Bio introduced Tapestri Single-cell Multiple Myeloma Multiomics Solution to accelerate the multiple myeloma (MM) research and therapeutic development. It is designed to offer comprehensive clonal and subclonal insights into disease evolution and biology at the single-cell level, featuring automated data analysis & reporting and compatibility with the existing Tapestri Instruments.
Challenges
- Complexity and expensiveness of this technique: Affordability and cost-effectiveness of the commodities from the single-cell omics market are significant considerations for their widespread implementation, especially in resource-limited settings or for small research institutes. Despite the efforts to provide financial support from government and manufacturing companies, the need for specialized equipment, reagents, and data analysis resources adds to the overall cost. In addition, the complicated procedure and pressure of regulatory compliance often creates a hurdle for worldwide adoption.
Single-cell Omics Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
17.8% |
|
Base Year Market Size (2025) |
USD 4.06 billion |
|
Forecast Year Market Size (2035) |
USD 20.89 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of single-cell omics is evaluated at USD 4.71 billion.
The global single-cell omics market size was worth over USD 4.06 billion in 2025 and is poised to witness a CAGR of over 17.8%, crossing USD 20.89 billion revenue by 2035.
The North America single-cell omics market is projected to capture a 40% share by 2035, driven by rising investment in advanced healthcare technologies, backed by the strong presence of global MedTech pioneers.
Key players in the market include Ultima Genomics, Inc., 10x Genomics, Inc., Becton, Dickinson and Company (BD), CELLENION, PerkinElmer Inc., ANGLE plc, Illumina, Inc., Bio-Rad Laboratories, Inc., Mission Bio, Inc., Standard BioTools Inc.
